Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin in Acute Non-purulent Exacerbations of COPD
NCT01091493Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jul 2010
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of moxifloxacin in chronic obstructive pulmonary disease (COPD), sponsored by Fundació Clínic per a la Recerca Biomèdica. Started Jul 2010; status: completed.
02
Drugs
moxifloxacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01091493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091493.